Marta Albanell (Marta Albanell-Fernández)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Multidrug Resistant

Breast Cancer Risk

Top Venues

Infectious diseases and therapy

Antibiotics (Basel, Switzerland)

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Judit Aranda, Jose Loureiro Amigo, Anna Murgadella, Núria Vàzquez, Lucía Feria, Miriam Muñoz Bolaño, Ariadna Padulles, Gabriela Abelenda, Carol Garcia-Vidal, Montserrat Tuset, Marta Albanell, Lucía Boix-Palop, Núria Sanmartí-Martínez, Inmaculada López Montesinos, Santiago Grau, Alicia Rodriguez-Alarcón, Beatriz Borjabad, Ana Coloma, Jordi Carratalà, Isabel Oriol
Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre Study. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Ángel Marcos Fendian, Marta Albanell, Montse Tuset, Cristina Pitart, Pedro Castro, Dolors Soy, Marta Bodro, Alex Soriano, Ana Del Río, José Antonio Martínez
Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infectious diseases and therapy (2023)
Marta Albanell, Ángela Pérez Sánchez, Inés Monge-Escartín, Gisela Riu, Mª Carmen Rodríguez Mues, Mª Lourdes Corominas Bosch, Lydia Gaba García, Neus Basté Rollán, Noemí Reguart, Dolors Soy Muner, Esther Carcelero San Martín
Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Ángel Marcos Fendian, Marta Albanell, Montse Tuset, Cristina Pitart, Pedro Castro, Dolors Soy, Marta Bodro, Alex Soriano, Ana Del Río, José Antonio Martínez
Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infectious diseases and therapy (2023)
Marta Albanell, Carla Bastida, Ángel Marcos Fendian, Jordi Mercadal, Pedro Castro-Rebollo, Dolors Soy-Muner
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients. European journal of hospital pharmacy : science and practice (2023)
Marta Albanell, Sara S Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-Martí, Andres Cervantes, Isabel Castro, Jose Martínez-Lillo, Gloria Ribas
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 15 (1) (2022)
Marta Albanell, Sara S Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-Martí, Andres Cervantes, Isabel Castro, Jose Martínez-Lillo, Gloria Ribas
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 15 (1) (2022)
Marta Albanell, Sara S Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-Martí, Andres Cervantes, Isabel Castro, Jose Martínez-Lillo, Gloria Ribas
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 15 (1) (2022)
Rubén González-García, Marta Albanell, Laura Aranda, Sonia Gelis, Joan Bartra, Dolors Soy Muner, Carmen López-Cabezas
Evaluation of desensitization protocols to betalactam antibiotics. Journal of clinical pharmacy and therapeutics (2021)